News | October 02, 2006

GE’s FASTLab Provides Turn-Key PET Tracers

GE Healthcare announced at the Annual Congress of the European Association of Nuclear Medicine in Athens, Greece, the release of FASTlab for PET radiopharmaceutical production, a part of GE’s strategy to develop new lines of radiopharmaceuticals, including diagnostic imaging agents.
FASTLab, a new, high-performance chemistry system, features a single-use cassette system which contains pre-measured quantities of all chemicals needed for the synthesis of radiopharmaceuticals accounting for its high yield and high reproducibility. Designed to deliver turn-key production of PET tracers, the first application launched on the platform is FDG for PET.
"The clinical utility of promising new PET tracers developed by academic and commercial research labs needs to be established through multi-institutional trials before they can be approved for common radiology practice", said Dr. Juri Gelovani, Professor of Radiology and Neurology at the University of Texas, MD Anderson Cancer Center. “For such multi-institutional trials, a strictly controlled and consistent cGMP-compliant production at each site or a centralized production and distribution of novel PET tracer candidates will be essential. FASTlab is an integrated cassette-based synthesis system, which will help to accelerate the set up and execution of these trials by providing a common platform for production of PET tracers under the same standard operating procedures (SOP). The goal is to make these innovative tracers available to patients and doctors as soon as possible and at the highest attainable quality.”

Related Content

Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
Feature | PET Imaging | November 07, 2018 | By Greg Freiherr
Positron emission tomography (PET) is getting ready to venture outside oncology, cardiology and mainstream neurology....
Podcast | PET Imaging | November 07, 2018
PET is getting ready to venture outside oncology, cardiology and mainstream neurology.
PET Imaging Offers New Possibilities in Chronic Liver Disease Management

Hepatic 18F-FDG, 18F-FAC, and 18F-DFA accumulation are affected in a mouse model of autoimmune hepatitis. (A) Histochemical and immunohistochemical analyses of liver sections from vehicle- and ConA-treated mice. Scale bars represent 50 microns. Transverse PET/CT images (B) and quantification (C) of vehicle- and ConA-treated mice injected with 18F-FDG, 18F-FAC, and 18FDFA. Livers are outlined in a white dotted line. Quantification represents radiotracer accumulation in the liver normalized to a background organ. Image courtesy of Salas J.R., Chen B.Y., Wong A., et al.

News | PET Imaging | October 24, 2018
While liver biopsies are powerful and reliable, they are also invasive, painful, limited and subject to complications....
Huntsman Cancer Institute Installs First Preclinical nanoScan 3T PET/MRI in U.S.
News | PET-MRI | October 10, 2018
The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI) at the University of Utah in Salt Lake...
Technology and Radionucleotide Development Will Fuel Mobile Gamma Camera Adoption
News | Nuclear Imaging | September 27, 2018
Advancements in healthcare technology, particularly in the surgery category, have led to an increasing adoption of...
Bruker Introduces New High-Performance Preclinical PET/CT Si78 System
Technology | PET-CT | September 26, 2018
September 26, 2018 — Bruker recently announced the introduction of the new preclinical...
PET Imaging Agent Predicts Brain Tau Pathology, Alzheimer's Diagnosis
News | PET Imaging | September 05, 2018
Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of positron emission tomography (PET)...